FHTX Foghorn Therapeutics Inc.companySEC Filings & Insider Trading Activity 2026
Latest Foghorn Therapeutics Inc. (FHTX) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 11, 2026, a 10-Q quarterly report filed on May 7, 2026, an 8-K current report filed on August 6, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Foghorn Therapeutics Inc. (FHTX) (SEC CIK 1822462), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Foghorn Therapeutics Inc.
Ask AI about FHTX filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting FHTX positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on FHTX.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Foghorn Therapeutics Inc. (FHTX) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Aug 6, 2026 | - | - | - |
8-K | Jun 24, 2026 | - | - | - |
10-Q | May 7, 2026 | Mar 31, 2026 | - | |
8-K | May 7, 2026 | - | - | |
8-K | Apr 21, 2026 | - | - | - |
8-K | Mar 11, 2026 | - | Analysis | - |
10-K | Mar 11, 2026 | Dec 31, 2025 | - | |
8-K | Feb 23, 2026 | - | Analysis | - |
8-K | Jan 12, 2026 | - | - | |
8-K | Dec 4, 2025 | - | - | |
10-Q | Nov 5, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 5, 2025 | Jun 30, 2025 | - | |
10-Q | May 14, 2025 | Mar 31, 2025 | - | |
10-K | Mar 6, 2025 | Dec 31, 2024 | - | |
10-Q | Nov 4, 2024 | Sep 30, 2024 | - | |
SC 13G | Sep 20, 2024 | - | - | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | - | |
SC 13G | May 30, 2024 | - | - | |
10-Q | May 6, 2024 | Mar 31, 2024 | - | |
10-K | Mar 7, 2024 | Dec 31, 2023 | - | |
10-Q | Nov 2, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 4, 2023 | Jun 30, 2023 | - | |
10-Q | May 8, 2023 | Mar 31, 2023 | - | |
10-K | Mar 9, 2023 | Dec 31, 2022 | - | |
10-Q | Nov 8, 2022 | Sep 30, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate FHTX share value held by 13F filers tracked by SignalX, by quarter.
- FMR LLC (Fidelity)+650.4K (+12%)
- Renaissance Technologies LLC+108.7K (+37%)
- Raymond James Financial+96.6K (+4%)
- State Street Corp+61.1K (+10%)
- AQR Capital Management+19.0K (+140%)
- Millennium Management179.0K (-86%)
- Ameriprise Financial158.7K (-26%)
- Wells Fargo & Co24.0K (-62%)
- Morgan Stanley23.3K (-19%)
- Bank of America Corp13.8K (-19%)
- Prudential Financial+12.2K
- Vanguard Group Inc−1.93M
- JPMorgan Chase & Co−17.2K
- Two Sigma Investments−16.6K
- Invesco Ltd−10.8K
Source: 13F-HR filings on SEC EDGAR (aggregated from 127 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest FHTX SEC filings in 2026?
Foghorn Therapeutics Inc. (FHTX) has filed a 10-K annual report on March 11, 2026, a 10-Q quarterly report on May 7, 2026, an 8-K current report on August 6, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did FHTX file its most recent 10-K annual report?
Foghorn Therapeutics Inc. (FHTX) filed its most recent 10-K annual report on March 11, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view FHTX 10-Q quarterly reports?
Foghorn Therapeutics Inc. (FHTX)'s most recent 10-Q quarterly report was filed on May 7, 2026. SignalX displays every FHTX 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has FHTX filed recently?
Foghorn Therapeutics Inc. (FHTX)'s most recent 8-K was filed on August 6, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find FHTX insider trading activity (Form 4)?
SignalX aggregates every FHTX Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does FHTX file with the SEC?
Foghorn Therapeutics Inc. (FHTX) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new FHTX filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Foghorn Therapeutics Inc. (FHTX).
What is FHTX's SEC CIK number?
Foghorn Therapeutics Inc. (FHTX)'s SEC CIK (Central Index Key) number is 1822462. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1822462 to look up all FHTX filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Foghorn Therapeutics Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 38+ filings.